You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vehicle

Showing 1 - 25 of 264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Neurotrophic Keratitis
  • BRM424 Ophthalmic Solution
  • Vehicle
  • (no location specified)
Jun 28, 2023

Generalized Epidermolysis Bullosa Simplex Trial (AC-203, Vehicle)

Not yet recruiting
  • Generalized Epidermolysis Bullosa Simplex
  • (no location specified)
Oct 3, 2023

Acute Infectious Keratoconjunctivitis Trial (INV-102, Vehicle)

Not yet recruiting
  • Acute Infectious Keratoconjunctivitis
  • (no location specified)
Jan 12, 2023

Dry Eye Disease Trial (BRM421 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Dry Eye Disease
  • BRM421 Ophthalmic Solution
  • Vehicle
  • (no location specified)
Jan 13, 2023

Itch Trial in Aalborg (CA and BAM8-22, Vehicle and BAM8-22 application, CA)

Completed
  • Itch
  • CA and BAM8-22
  • +3 more
  • Aalborg, Denmark
    Aalborg University
Sep 7, 2023

Pterygium Trial in Delray Beach (CBT-001, Vehicle)

Recruiting
  • Pterygium
  • Delray Beach, Florida
    Bruce A. Segal, MD
Jul 18, 2022

Hand Eczema Trial (Ruxolitinib cream, Vehicle)

Not yet recruiting
  • Hand Eczema
  • Ruxolitinib cream
  • Vehicle
  • (no location specified)
Jun 7, 2023

Atopic Dermatitis Trial in Woolloongabba, Adelaide (FMX114, Vehicle)

Completed
  • Atopic Dermatitis
  • Miami, Florida
  • +6 more
Aug 25, 2022

Acquired Blepharoptosis Trial (LEV102 1.0%, LEV102 2.0%, Vehicle)

Not yet recruiting
  • Acquired Blepharoptosis
  • LEV102 1.0%
  • +2 more
  • (no location specified)
Feb 6, 2023

Sexual Arousal Disorder Trial (Sildenafil, Vehicle, Placebo)

Not yet recruiting
  • Sexual Arousal Disorder
  • (no location specified)
Mar 10, 2023

Dry Eye Syndrome Trial in Italy, United States (Oxervate, Vehicle)

Active, not recruiting
  • Dry Eye Syndrome
  • Glendale, California
  • +10 more
Feb 1, 2023

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • OTX-101 0.05%
  • +2 more
  • Cleveland, Ohio
    (unnamed)
Aug 26, 2022

Dry Eye Trial in Durham (VVN001 Ophthalmic Solution 1%, VVN001 Ophthalmic Solution 5%, Vehicle)

Completed
  • Dry Eye
  • VVN001 Ophthalmic Solution 1%
  • +2 more
  • Durham, North Carolina
    Lexitas
Jan 31, 2022

Rosacea Trial in Worldwide (CLS001 (Omiganan), Vehicle)

Completed
Has Results
  • Rosacea
  • CLS001 (Omiganan)
  • Vehicle
  • Fremont, California
  • +40 more
Jul 31, 2022

Persistent Corneal Epithelial Defect Trial in United States (lufepirsen, Vehicle)

Recruiting
  • Persistent Corneal Epithelial Defect
  • Pasadena, California
  • +5 more
Jul 21, 2023

Dry Eye Trial in Italy, United States (Oxervate, Vehicle)

Active, not recruiting
  • Dry Eye
  • Glendale, California
  • +10 more
Oct 24, 2022

Atopic Dermatitis Trial in Culver City (Ruxolitinib cream, Vehicle)

Recruiting
  • Atopic Dermatitis
  • Ruxolitinib cream
  • Vehicle
  • Culver City, California
    Science37
Jan 12, 2023

Dry Eye Disease Trial in Rush (INV-102, Vehicle)

Recruiting
  • Dry Eye Disease
  • Rush, New York
    iuvo BioScience
Jan 12, 2023

Presbyopia Trial in United States (CSF-1, Vehicle)

Completed
  • Presbyopia
  • Newport Beach, California
  • +12 more
Dec 13, 2022

Dry Eye Trial in United States (Vehicle, SDP-4 Ophthalmic Solution (1.0%))

Completed
Has Results
  • Dry Eye
  • Vehicle
  • SDP-4 Ophthalmic Solution (1.0%)
  • Garden Grove, California
  • +4 more
Aug 11, 2022

Congenital Ichthyosis Trial in Australia, United States (Isotretinoin, Vehicle)

Completed
Has Results
  • Congenital Ichthyosis
  • Phoenix, Arizona
  • +10 more
Aug 3, 2022

Active, Symptomatic Blepharitis Trial in Newport Beach (ISV-305, Vehicle)

Completed
Has Results
  • Active, Symptomatic Blepharitis
  • Newport Beach, California
    Clinical Research Center
Nov 18, 2021

Corneal Persistent Epithelial Defect Trial in Edgewood (NEXAGON High Dose Concentration, NEXAGON Low Dose Concentration, NEXAGON

Recruiting
  • Corneal Persistent Epithelial Defect
  • Nexagon® (lufepirsen) High Dose Concentration
  • +3 more
  • Los Angeles, California
  • +4 more
Aug 25, 2022

Diabetic Macular Edema Trial in Beverly Hills (Active treatment arm: OCS-01 (dexamethasone), Vehicle)

Active, not recruiting
  • Diabetic Macular Edema
  • Active treatment arm: OCS-01 (dexamethasone)
  • Vehicle
  • Beverly Hills, California
    Oculis Investigative Site
Jan 13, 2023

Conjunctivitis, Vernal Trial in Paris (Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle)

Completed
Has Results
  • Conjunctivitis, Vernal
  • Cyclosporine NOVA22007 0.05%
  • +2 more
  • Paris, France
    Groupe Hospitalier Bichat-Claude Bernard
Nov 12, 2021